BioNxt Solutions Inc. (BNXT)

BRIEF

published on 12/19/2024 at 09:10, 2 days 6 hours ago

BioNxt Solutions élargit son portefeuille de brevets pour ses innovations en matière d'administration de médicaments

Sclérose En Plaques Innovation Pharmaceutique Solutions BioNxt Extension Du Brevet Administration Sublinguale
BRIEF

published on 12/19/2024 at 09:10, 2 days 6 hours ago

BioNxt Solutions Expands Patent Portfolio for Drug Delivery Innovations

Multiple Sclerosis BioNxt Solutions Sublingual Delivery Patent Expansion Drug Innovation
PRESS RELEASE

published on 12/19/2024 at 09:05, 2 days 6 hours ago

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP
BioNxt Solutions Inc. expands its intellectual property portfolio with new international patents for sublingual delivery technologies targeting autoimmune neurodegenerative diseases. The company aims to bring patient-friendly therapies to individuals affected by these diseases

BioNxt Solutions Inc. Intellectual Property Patents Autoimmune Neurodegenerative Diseases Sublingual Delivery Technologies
BRIEF

published on 12/09/2024 at 09:10, 12 days 6 hours ago

BioNxt Solutions développe le BNT23001 pour le traitement de la sclérose en plaques

Essais Cliniques Sclérose En Plaques Développement De Médicaments Solutions BioNxt BNT23001
BRIEF

published on 12/09/2024 at 09:10, 12 days 6 hours ago

BioNxt Solutions Advances BNT23001 for MS Treatment

Clinical Trials Drug Development Multiple Sclerosis BioNxt Solutions BNT23001
PRESS RELEASE

published on 12/09/2024 at 09:05, 12 days 6 hours ago

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
BioNxt Solutions Inc. achieves key milestones in the development of BNT23001, a sublingual thin-film formulation of Cladribine for Multiple Sclerosis treatment, paving the way for clinical trials and regulatory submissions in 2025

Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Sublingual Thin-Film BNT23001
BRIEF

published on 12/02/2024 at 09:10, 19 days 6 hours ago

BioNxt Solutions développe un film mince sublingual pour le sémaglutide

Solutions BioNxt Conformité Des Patients Semaglutide Couche Mince Sublinguale Innovation Dans L'administration Des Médicaments
BRIEF

published on 12/02/2024 at 09:10, 19 days 6 hours ago

BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide

Drug Delivery Innovation BioNxt Solutions Patient Compliance Sublingual Thin-Film Semaglutide
PRESS RELEASE

published on 12/02/2024 at 09:05, 19 days 6 hours ago

BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
BioNxt Solutions Inc. introduces sublingual thin-film oral dissolvable film (ODF) for Semaglutide, enhancing patient experience and improving drug delivery

Innovation Healthcare BioNxt Solutions Inc. Drug Delivery Semaglutide
BRIEF

published on 11/25/2024 at 09:10, 26 days 6 hours ago

BioNxt Expands Sublingual Product Pipeline with Innovations

BioNxt Solutions Sublingual Technology Autoimmune Treatments Longevity Market Drug Delivery Systems

1 2 ... 8

Published on 12/21/2024 at 01:30, 14 hours 3 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 3 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 28 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 33 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 3 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 41 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 48 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 22 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 37 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 33 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 15 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 15 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 33 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 33 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 38 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News